# Next Step Evidence Summary: Biological Counter-Curvature

*Date: 2026-02-19*
*Context: Consolidation of AlphaFold structural evidence and metric freshness.*

## What is Stronger Now Than Baseline
1. **Structural Anchors Clarified**: The distinction between true "Tension Rods" (high anisotropy + high confidence, e.g., PIEZO2, FBLN5, CNNM2) and exploratory candidates (high anisotropy + low confidence, e.g., POC5, GHR) is now quantitatively established via confidence-weighting (`outputs/afcc/confidence_weighted_ranking.csv`).
2. **Claim Discipline Enforced**: The creation of the `reports/countercurvature_claims_matrix.md` rigorously separates measured structural data from speculative narrative, providing a clean foundation for manuscript drafting.
3. **Data Provenance Secured**: The `reports/evidence_freshness_audit.md` explicitly flags static metric reuse, preventing the inflation of hypotheses based on redundant data processing.

## What Remains Weak (Evidence AGAINST current hypothesis)
1. **LBX1's Structural Role**: The data strongly weakens the hypothesis that LBX1 is a primary, load-bearing mechanosensor or "Tension Rod". Its low anisotropy (2.27) and low confidence (pLDDT 66.9) categorize it as an intermediate, potentially disordered or context-dependent protein. Narratives assigning it a rigid structural role are unsupported by current AlphaFold data.
2. **Over-Interpretation of Static Data**: The freshness audit revealed that "emerging" structural narratives for core genes (LBX1, PIEZO2, LMNA) were sometimes generated despite their underlying structural metrics remaining completely static across multiple runs (Jan 09 - Feb 16).

## Top 3 Highest-Leverage Next Experiments
To move the Biological Counter-Curvature framework from computational inference to empirical validation, we must execute the following:

1. **Orthogonal Validation of Low-Confidence Outliers (POC5, GHR)**:
   * **Why**: High anisotropy + low pLDDT suggests these might be intrinsically disordered regions that only adopt extended conformations upon binding.
   * **Action**: Perform in-cell crosslinking mass spectrometry (XL-MS) or use structural biology techniques (Cryo-EM/NMR on specific domains) to verify their in vivo extended state.
2. **Functional Falsification of LBX1 Mechanotransduction**:
   * **Why**: To definitively resolve whether LBX1 has a mechanical role despite its unconvincing monomeric structure.
   * **Action**: Execute Experiment 1 from `reports/lbx1_falsifiability_plan.md`: perturb nuclear tension (LINC disruption/substrate stiffness) and quantify changes in LBX1 chromatin association.
3. **Multimeric Context Modeling**:
   * **Why**: The current AlphaFold metrics are derived from monomeric predictions. Mechanosensors and structural scaffolds function as complexes.
   * **Action**: Run AlphaFold-Multimer on key complexes (e.g., LBX1 with known binding partners, PIEZO2 homomeric complexes) to see if multimerization rescues pLDDT and alters the predicted anisotropy/blockiness.
